Lazard Asset Management LLC Amphastar Pharmaceuticals, Inc. Call Options Transaction History
Lazard Asset Management LLC
- $82.4 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AMPH
# of Institutions
276Shares Held
33.4MCall Options Held
56.6KPut Options Held
57.3K-
Black Rock Inc. New York, NY6.08MShares$229 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.73MShares$103 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA2.08MShares$78.4 Million0.21% of portfolio
-
Neuberger Berman Group LLC New York, NY1.66MShares$62.7 Million0.06% of portfolio
-
State Street Corp Boston, MA1.51MShares$57.2 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.85B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...